Max Robotics — Global Service Robot Directory + US Certification

About

Arnav Agarwal is a leading clinical researcher whose work focuses on perioperative thromboprophylaxis, with a particular emphasis on balancing the risks of venous thromboembolism (VTE) and bleeding in urological surgery. His most-cited paper, a 2017 systematic review and meta-analysis on procedure-specific risks of thrombosis and bleeding in urological cancer surgery (126 citations), provides critical baseline risk estimates that guide the safe use of pharmacological prophylaxis. This work directly informs the challenging trade-off between preventing life-threatening clots and avoiding surgical bleeding complications. Agarwal also led an international survey (2020) that characterized significant global practice variation in thromboprophylaxis use, highlighting the need for standardized, evidence-based guidelines. Through these contributions, he has advanced patient safety in urological oncology by equipping surgeons with data-driven tools to personalize perioperative care. His research is widely cited by clinicians and guideline committees, underscoring its practical impact on surgical decision-making and the prevention of thromboembolic events in high-risk populations.